|
|
||||||||
Departments of Medicine and Integrative Biology, Pharmacology and Physiology, University of Texas Medical School at Houston, Houston, Texas 77030; and Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha, Nebraska 68198-4575.
| |
ABSTRACT |
|---|
|
|
|---|
The influence of arachidonic acid (AA) on the feedback regulation of mesangial contraction by large Ca2+-activated K+ channels (BKCa) was determined through single-channel analysis using the patch clamp method. The mesangial BKCa is a low-gain negative feedback inhibitor of contraction that is activated in response to agonist-induced Ca2+ transients and membrane depolarization. AA activated BKCa in cell-attached patches in a dose-dependent manner with a maximal effect at 400 nM and a half-maximal response at 49 nM. In inside-out patches, AA directly activated BKCa with a maximal effect at 400 nM. BKCa was activated significantly in response to addition of 100 nM ANG II in the presence but not the absence of AA. Since it was shown previously that fatty acids stimulated both soluble and membrane-bound guanylyl cyclase, we determined whether AA activated BKCa by interfering with cGMP-mediated signal transduction pathways. It was previously shown that 10 µM cGMP, via cGMP-dependent protein kinase, activated BKCa in a biphasic manner with an early increase in probability of a channel existing in an open state (Po) and a subsequent inactivation mediated by protein phosphatase 2A (PP2A). We found that 10 µM dibutyryl-cGMP enhanced BKCa activity in an additive manner with saturating concentrations (400 nM) of AA. Moreover, the inactivation phase mediated by PP2A was not abolished. Thus AA does not affect the phosphorylation/dephosphorylation regulatory cycle for BKCa. It is concluded that AA potentiates the ANG II feedback response of BKCa by a mechanism that is independent of the phosphorylation cycle.
BKCa calcium-activated potassium channels; guanosine 3',5'-cyclic monophosphate; fatty acids
| |
INTRODUCTION |
|---|
|
|
|---|
GLOMERULAR MESANGIAL cells (MC) are smooth-muscle- like contractile cells that are important regulators of renal hemodynamics. By surrounding the glomerular capillaries, MC regulate filtratable surface area and maintain filtration rates within physiological limits. Like vascular smooth muscle, the contractile tone of MC is governed by the influences of multiple systemic and local hormone agonists. Contractile agonists, such as ANG II and endothelin-1, and relaxants, such as atrial natriuretic peptide (ANP) and nitric oxide (NO), respectively, contract and relax MC by influencing the activities of plasmalemmal ion-selective channels.
Our laboratory has recently described one mechanism by which ANP and NO regulate MC tone. Through cGMP-signal transduction, these vasodilating agents activate large, Ca2+-activated K+-selective ion channels (BKCa) (26). In both vascular smooth muscle (3) and glomerular MC (21, 24), BKCa are feedback regulators of contraction. Agonist-induced elevations in intracellular Ca2+ and depolarization of membrane potential activate BKCa, which hyperpolarizes the plasma membrane and subsequently inactivates or blocks activation of voltage-gated Ca2+-entry channels. Thus cGMP signal transduction increases the feedback gain and potentiates the attenuation of agonist-induced Ca2+ entry.
Arachidonic acid (AA), a saturated, long-chain fatty acid, is a ubiquitous modulator of several types of ion channels (16) and may have an important role in cell signaling mechanisms. Several studies have shown that K+-selective channels other than BKCa were modulated directly by AA (12, 13, 15-17, 29). That BKCa are activated directly by AA was demonstrated in vascular smooth muscle (14) and brain cells (5). The indirect activation of BKCa (by metabolites) was demonstrated in brain (6) and small renal arteries (35).
Large, Ca2+-activated K+ channels from different cell types, such as brain, vascular smooth muscle, and MC, are differentially regulated by cell signaling pathways. For example, BKCa from rat brain are regulated by cAMP-activated kinase (19). BKCa from pituitary tumor cells (GH4C1) (30, 31) and some vascular smooth muscle cells (34) are activated when dephosphorylated by cGMP-dependent protein phosphatase. However, BKCa from MC are activated by cGMP-dependent protein kinase (25) and inactivated by protein phosphatase 2A (PP2A) (22). Thus the pathways for regulating BKCa are cell specific.
Since MC are important regulators of glomerular filtration rate, it is important to determine the signal transduction pathways for regulating the ion channels that govern contraction. Studies have shown that both the membrane-bound (28) and particulate (2) forms of guanylyl cyclase are stimulated by free fatty acids (FFA). Thus these studies were performed to determine whether low concentrations of AA could enhance the feedback response of BKCa to ANG II and whether cGMP-activated protein kinase or PP2A was an intermediary for this effect.
|
| |
METHODS |
|---|
|
|
|---|
MC cultures. Human MC, originally isolated by the laboratory of Hanna Abboud, were obtained at the fifth generation and subcultured by standard methods previously described (11). The medium (Waymouth, pH 7.4) was supplemented with 10 mM HEPES, 2.0 mM glutamine, 0.66 U/ml insulin, 1.0 mM sodium pyruvate, 0.1 mM nonessential amino acids, antibiotic solution (100 U/ml penicillin and 100 µg/ml streptomycin), and 17% fetal bovine serum. For single-channel analysis, cells were grown on 22 × 22-mm cover glasses, #1 type (no. 1 type; Fisher, Pittsburgh, PA) and maintained in a humidified tissue culture incubator at 37°C and 5% CO2 (IR Autoflow; Nuaire, Plymouth, MN). Only subpassages 5-10 were used, as MC maintain both the phenotypic shape that is characteristic of smooth muscle cells and exhibit BKCa during these generations.
Patch-clamp procedure. The bathing
solution for inside-out experiments and the pipette solution for all
experiments contained (in mM) 140 KCl, 10 HEPES, 2 MgCl2, and 0.001 CaCl2, pH 7.4. For cell-attached
patches, the bath solution (physiological saline) contained (in mM) 135 NaCl, 5 KCl, 10 HEPES, 2 MgCl2,
and 1 CaCl2. The free
Ca2+ concentration of the bath was
adjusted from 1 mM to 1.0 µM by buffering with 1.08 mM EGTA. The
amount of added EGTA was calculated using the calcium concentration
program by MTK Software. Single-channel analysis was made at 23°C
using standard patch-clamp techniques (9). The pipette was inserted
into a polycarbonate holder, connected to the head stage of the patch
amplifier (L/M-EPC 7; Adams and List, Great Neck, NY) by a Ag-AgCl
wire, and then lowered onto the cell. A high-resistance (>5 G
)
seal between the pipette and MC membrane was obtained by applying
suction.
Upon obtaining a seal, current recordings of
BKCa were made with the pipette
attached to the membrane (cell attached) or after withdrawing the patch
of membrane from the cell (excised, inside-out). BKCa were immediately identified
by the characteristic magnitude of single-channel current and
voltage-gating properties as previously described in this laboratory
(24). The unitary current (i), defined as zero for the closed state (C), was determined as the mean of
the best-fit Gaussian distribution of the amplitude histograms. Channels were considered to be in an open state (S) when the current was >(n
1/2)i and
<(n + 1/2)i, where
n is the maximum number of current
levels observed. The probability of a channel existing in an open state
(Po) is defined
as the time spent in a conducting state (S) divided by the total time
of the recording. The time in a conducting state was calculated using
the best-fit Gaussian distribution of the amplitude histogram. When
more than one channel occupied a patch, open probability was calculated
by dividing by 1 minus the number of current levels the total of the
sum of the frequency of observing a given current state times the
appropriate current level (conducting state). To enable
accurate calculations of open probability in cell-attached patches, the
number of channels was determined after excising the patch into a
bathing solution containing 1 mM
Ca2+. At this concentration of
Ca2+ and a command potential of 40 mV, the open probability is greater than 0.80 (24). If the number of
channels could not be determined, then the channel activity was
calculated as NPo =
nPn, where Pn is the
probability of finding n channels
open. To obtain a dose-response curve, the data were fit to the
Michaelis-Menten equation,
NPo =
NPo max × [AA/(Km + AA)], where
NPo max
is the maximum change in open probability, and the
Km is the
concentration of AA that results in a half-maximal increase in
NPo.
Currents were recorded onto the hard drive of a Compaq Presario Pentium computer using the Axoscope acquisition program. Analysis was performed using pClamp program set 6.0 (Axon Instruments, Foster City, CA).
Protocol. To determine the effects of AA on BKCa, concentrations of 4 nM to 4 µM AA were added to the bathing solution, and the Po was monitored in cell-attached and excised patches. To determine the effects of AA on BKCa feedback, ANG II (100 nM) was added to the bathing solution in the presence or absence of 400 nM or 4 µM AA. The interaction of AA with cGMP was determined by monitoring the Po of BKCa after adding dibutyryl-cGMP (DB-cGMP, 10 µM) to the bathing solution in the absence and presence of 400 nM AA.
AA, purchased from Sigma Chemical, was dissolved in 1% methanol and stored at 0°C as 100 mg/ml stock.
| |
RESULTS |
|---|
|
|
|---|
Effects of AA on BKCa. Figure 1 shows dose-response relations for the activation of BKCa by AA in cell-attached patches. As shown in the tracings of the first patch (Fig. 1A), the activity of BKCa increased from a control value (NPo) of 0.001 to 0.01, 0.15, and 0.30 after subsequent additions of 4, 40, and 400 nM AA, respectively. The NPo reversed to 0.010 after flushing AA. In the second patch (Fig. 1B), NPo increased from 0.002 in control to 0.033 after addition of 40 nM and to 1.02 after addition of 400 nM. After flushing AA, the baseline NPo was 0.62. Addition of 4 µM AA increased NPo to 0.97. The data are summarized in the dose-response curve (Fig. 1C). After fitting the curve to the Michaelis-Menten equation, the maximal response to AA is 0.24, and the concentration of AA resulting in a half-maximal response (Km) is 49 nM.
Figure 2 shows the response of BKCa to 4 µM AA in inside-out patches. In this patch, the Po of BKCa was increased from 0.05 to 0.20 by 4 µM AA. For the inside-out patches in which the Po of BKCa could be determined, it was found that the Po values for the effects of 400 nM (0.17 ± 0.02, n = 3), 4 µM (0.15 ± 0.04, n = 7), and 40 µM (0.18 ± 0.04, n = 3) AA were not significantly different. Thus the effects of AA are saturating at 400 nM in excised patches.
|
|
|
Effects of AA on the activation of BKCa by cGMP. Since it was shown previously that BKCa are activated by cGMP-dependent protein kinase and inhibited by PP2A, the following experiments were performed to determine whether AA affected the phosphorylation cycle of BKCa. The tracings of Fig. 5 show the effects of DB-cGMP in the absence and presence of 400 nM AA. As shown previously, BKCa are activated transiently by DB-cGMP from 0.001 to 0.46 (peak activity) after 10 s. The rundown phase was previously shown to be the result of subsequent inhibition by PP2A. In the presence of 400 nM AA, the basal Po was 0.04. Addition of DB-cGMP activated BKCa to 0.21 after 10 s, and the Po returned to baseline after 20 s.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
The BKCa channels of both vascular smooth muscle (3) and MC (24) serve as feedback regulators of contraction. In vascular smooth muscle, BKCa activate in response to depolarization and elevated intracellular Ca2+ concentration, bringing the membrane potential back to resting values (3). In MC, the gain in this feedback response is minimal in the absence of relaxing agents, such as NO and ANP (26). The results of the present study showed that the gain in the feedback response of BKCa can be potentiated by low concentrations of AA. The effects of AA are independent of phosphorylation by cGMP-activated kinase and dephosphorylation by PP2A and are consistent with a direct activation of BKCa.
Mechanism of action of AA. There are several possible mechanisms for the enhancement by AA of the BKCa-mediated feedback control of contraction. One possibility is that AA increases the fluidity of the membrane, which changes the selectivity to divalent cations of the Ca2+ binding site on BKCa. Bregestovski et al. (4) found that the fatty acid 2-decanoic acid, shown previously to enhance membrane fluidity, increased the activity of BKCa in human aortic smooth muscle by increasing its sensitivity to Mg2+. Since the cytoplasmic solutions of the present study contained Mg2+, it is possible that AA increased the sensitivity of BKCa to Mg2+, which could serve as a better activator of BKCa than Ca2+.
It is also possible that AA affects the Ca2+ activity in close proximity to BKCa. In support of this theory, some investigators have suggested that AA increases intracellular release of Ca2+ from intracellular stores and augments Ca2+ influx (20). However, the direct activation of BKCa by AA in inside-out patches does not support this theory. Moreover, Ordway et al. (18) found that FFA activated smooth muscle K+ channels in the complete absence of Ca2+ (5 mM EGTA).
AA also may influence a membrane-associated regulator of BKCa. Our laboratory has shown that BKCa is activated by protein kinase G (25) and inactivated by PP2A (22). Both enzymes are likely closely associated with the membrane. Because some studies have shown that AA activates guanylyl cyclase (7, 10) and inhibits myosin light chain phosphatase (8), we investigated the possibility that AA activates BKCa by interacting with cGMP-activated kinase or PP2A. The finding that DB-cGMP activated BKCa transiently and to the same magnitude in the presence and absence of AA suggests that the mechanism does not involve guanylyl cyclase, cGMP, cGMP-activated protein kinase, and PP2A.
The mechanism of activation of BKCa by AA can be determined, in part, by studying the actions of a variety of other fatty acids. Although the present study has not focused on the specific molecular requirements for activation of BKCa by fatty acids, other investigators have studied the effects of varying the length and the number of double bonds of fatty acids. Ordway et al. (17) found that BKCa could be activated by polyunsaturated fatty acids such as AA and also by monounsaturated and saturated FFA, such as linoelaidic and myristic acid, respectively. They concluded that the primary requirement was the solubility of the FFA.
It is significant that myristic acid activated BKCa, since it is not a substrate for cyclooxygenase and lipoxygenase enzymes. Moreover, the finding that K+ channels can be activated in the presence of eicosatetraenoic acid (18), an inhibitor of AA metabolic pathways, suggests that AA, and not the metabolites of AA, is directly activating BKCa in MC. On the other hand, BKCa of small renal arteries of the rat were directly activated by the epoxygenase metabolite, 11,12-epoxyeicosatrienoic acid (R,S isomer) (35), and BKCa of bovine adrenal medullary chromaffin cells were activated by the lipoxygenase metabolite 15-hydroxyperoxyeicosatetraenoic acid (27). Thus more studies are needed to determine the effects of AA metabolites on the mesangial BKCa.
The data from the present and other studies suggest that AA activates BKCa by directly interacting with the channel protein. It is not known whether K+ channels have binding sites for AA; however, it is known that other proteins such as albumin contain specific binding sites for FFA (23).
Physiological and pathophysiological significance of AA-activated BKCa. Although several studies have shown that ion channels are regulated by AA (12, 13, 15-17, 29), the physiological significance of this signaling pathway is still speculative. Some investigators suggest that AA is elevated in the serum and cytosol during cardiac ischemia (16). Activation of K+ channels would reduce the action potential and load on the heart. Similarly, glomerular ischemia would elevate AA resulting in an attenuated contractile response to ANG II and an enhancement of the relaxing effects of ANP and NO. The reduced tension in MC would conserve ATP.
Several studies have documented an increase in fatty acid metabolism in cells grown under the simulated pathological conditions of diabetes (32, 33). Williams and Schrier (32) have shown that AA release is significantly elevated when cultured rat MC are grown in high ambient glucose concentrations. High intracellular glucose directly metabolizes to diacylglycerol, an activator of protein kinase C, which, in turn, activates phospholipase A2 (PLA2) and releases AA. PLA2 activity and AA levels are elevated under conditions of glomerular damage and high blood glucose. The pathological modulation of the mesangial BKCa and subsequent elevation of filtration rate by AA may partly explain the hyperfiltration associated with the early stages of diabetes mellitus (1). In summary, these results show that mesangial BKCa, like that of brain BKCa, is activated directly by low concentrations of AA. The effects of AA augment the feedback response to ANG II by a mechanism independent of phosphorylation by cGMP-dependent kinase and dephosphorylation by PP2A. These results indicate that elevated physiological or pathophysiological concentrations of AA can affect the contractility of MC and could partially explain the hyperfiltration in the early stages of diabetes mellitus.| |
ACKNOWLEDGEMENTS |
|---|
The human mesangial cells were kindly supplied by Dr. Hanna Abboud from the University of Texas, San Antonio, TX. This study was supported by American Diabetes Award 89 and National Institute of Diabetes and Digestive and Kidney Diseases Grant DK-49561 (all to S. C. Sansom).
| |
FOOTNOTES |
|---|
Present address of J. D. Stockand: Emory Univ. Medical School, Dept. of Physiology, Center for Cell and Molecular Signaling, Atlanta, GA 30322.
Address for reprint requests: S. C. Sansom, Univ. of Nebraska Medical Center, Dept. of Physiology and Biophysics, 600 South 42nd St., Omaha, NE 68198-4575.
Received 2 May 1997; accepted in final form 9 January 1998.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bank, N.
Mechanisms of diabetic hyperfiltration.
Kidney Int.
40:
792-807,
1991[Medline].
2.
Braughler, J. M.,
C. K. Mittal,
and
F. Murad.
Purification of soluble guanylate cyclase from rat liver.
Proc. Natl. Acad. Sci. USA
76:
219-222,
1979
3.
Brayden, J. E.,
and
M. T. Nelson.
Regulation of arterial tone by activation of calcium-dependent potassium channels.
Science
256:
532-535,
1992
4.
Bregestovski, P. D.,
V. M. Bolotina,
and
V. N. Serebryakov.
Fatty acid modifies Ca2+-dependent potassium channel activity in smooth muscle cells from the human aorta.
Proc. R. Soc. Lond.
237:
259-266,
1989.[Medline]
5.
Denson, D. D.,
R. T. Worrell,
and
D. C. Eaton.
A possible role for phospholipase A2 in the action of general anesthetics.
Am. J. Physiol.
270 (Cell Physiol. 39):
C636-C644,
1996
6.
Duerson, K.,
R. E. White,
F. Jiang,
A. Schonbrunn,
and
D. L. Armstrong.
Somatostatin stimulates BKCa channels in rat pituitary tumor cells through lipoxygenase metabolites of arachidonic acid.
Neuropharmacology
35:
949-961,
1996[Medline].
7.
Gerzer, R.,
P. Hamet,
A. H. Ross,
J. A. Lawson,
and
J. G. Hardman.
Calcium-induced release from platelet membranes of fatty acids that modulate soluble guanylate cyclase.
J. Pharmacology Exp. Ther.
226:
180-186,
1983
8.
Gong, M. C.,
A. Fuglsang,
D. Alessi,
S. Kobayashi,
P. Cohen,
A. V. Somlyo,
and
A. P. Somlyo.
Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium.
J. Biol. Chem.
267:
21492-21498,
1992
9.
Hamill, O. P.,
A. Marty,
E. Neher,
B. Sakmann,
and
F. J. Sigworth.
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.
Pflügers Arch.
391:
85-100,
1981[Medline].
10.
Ignarro, L. J.,
and
K. S. Wood.
Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme.
Biochim. Biophys. Acta
928:
160-170,
1987[Medline].
11.
Jaffer, F.,
C. Saunders,
P. Shultz,
D. Throckmorton,
E. Weinshell,
and
H. E. Abboud.
Regulation of mesangial cell growth by polypeptide mitogens.
Am. J. Pathol.
135:
261-269,
1989[Abstract].
12.
Kim, D.,
and
D. E. Clapham.
Potassium channels in cardiac cells activated by arachidonic acid and phospholipids.
Science
244:
1174-1179,
1989
13.
Kim, D.,
C. D. Sladek,
C. Aguado-Velasco,
and
J. R. Mathiasen.
Arachidonic acid activation of a new family of K+ channels in cultured rat neuronal cells.
J. Physiol. (Lond.)
484:
643-660,
1995[Medline].
14.
Kirber, M. T.,
R. W. Ordway,
L. H. Clapp,
J. V. Walsh, Jr.,
and
J. J. Singer.
Both membrane stretch and fatty acids directly activate large conductance Ca2+-activated K+ channels in vascular smooth muscle cells.
FEBS Lett.
297:
24-28,
1992[Medline].
15.
Macica, C. M.,
Y. H. Yang,
S. C. Hebert,
and
W. H. Wang.
Arachidonic acid inhibits activity of cloned renal K+ channel, ROMK1.
Am. J. Physiol.
271 (Renal Fluid Electrolyte Physiol. 40):
F588-F594,
1996
16.
Meves, H.
Modulation of ion channels by arachidonic acid.
Prog. Neurobiol.
43:
175-186,
1994[Medline].
17.
Ordway, R. W.,
J. J. Singer,
and
J. V. Walsh, Jr.
Direct regulation of ion channels by fatty acids.
Trends Neurosci.
14:
96-100,
1991[Medline].
18.
Ordway, R. W.,
J. V. Walsh,
and
J. J. Singer.
Arachidonic acid and other fatty acids directly activate potassium channels in smooth muscle cells.
Science
244:
1176-1179,
1989
19.
Reinhart, P. H.,
S. Chung,
B. L. Martin,
D. L. Brautigan,
and
I. B. Levitan.
Modulation of calcium-activated potassium channels from rat brain by protein kinase A and phosphatase 2A.
J. Neurosci.
11:
1627-1635,
1991[Abstract].
20.
Roudbaraki, M. M.,
P. Vacher,
and
R. Drouhault.
Arachidonic acid increases cytosolic calcium and stimulates hormone release in rat lactotrophs.
Am. J. Physiol.
268 (Endocrinol. Metab. 31):
E1215-E1223,
1995
21.
Sansom, S. C.,
and
J. D. Stockand.
Physiological role of large, Ca-activated K channels in human glomerular mesangial cells.
Clin. Exp. Pharm. and Physiol.
23:
76-82,
1996[Medline].
22.
Sansom, S. C.,
J. D. Stockand,
D. Hall,
and
B. Williams.
Regulation of large calcium-activated potassium channels by protein phosphatase 2A.
J. Biol. Chem.
272:
9902-9906,
1997
23.
Spector, A. A.
Fatty acid binding to plasma albumin.
J. Lipid Res.
16:
165-179,
1997[Abstract].
24.
Stockand, J. D.,
and
S. C. Sansom.
Large Ca2+-activated K+ channels responsive to angiotensin II in cultured human mesangial cells.
Am. J. Physiol.
267 (Cell Physiol. 36):
C1080-C1086,
1994
25.
Stockand, J. D.,
and
S. C. Sansom.
Mechanism of activation by cGMP-dependent protein kinase of large Ca2+-activated K+ channels in mesangial cells.
Am. J. Physiol.
271 (Cell Physiol. 40):
C1669-C1677,
1996
26.
Stockand, J. D.,
and
S. C. Sansom.
Role of large, Ca-activated K channels in regulation by nitroprusside and ANP of mesangial contraction.
Am. J. Physiol.
270 (Cell Physiol. 39):
C1773-C1779,
1996
27.
Twitchell, W. A.,
T. L. Peña,
and
S. G. Rane.
Ca2+-dependent K+ channels in bovine adrenal chromaffin cells are modulated by lipoxygenase metabolites of arachidonic acid.
J. Membr. Biol.
158:
69-75,
1997[Medline].
28.
Wallach, D.,
and
I. Pastan.
Stimulation of guanylate cyclase of fibroblasts by free fatty acids.
J. Biol. Chem.
251:
5802-5809,
1976
29.
Wang, W.,
A. Cassola,
and
G. Giebisch.
Arachidonic acid inhibits the secretory K+ channel of cortical collecting duct of rat kidney.
Am. J. Physiol.
262 (Renal Fluid Electrolyte Physiol. 31):
F554-F559,
1992
30.
White, R. E.,
A. B. Lee,
A. D. Shcherbatco,
T. M. Lincoln,
A. Schonbruan,
and
D. L. Armstrong.
Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation.
Nature
361:
263-266,
1993[Medline].
31.
White, R. E.,
A. Schonbruan,
and
D. L. Armstrong.
Somatostatin stimulates Ca2+-activated K+ channels through protein dephosphorylation.
Nature
351:
570-573,
1991[Medline].
32.
Williams, B.,
and
R. W. Schrier.
Glucose-induced protein kinase C activity regulates arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells.
J. Clin. Invest.
92:
2889-2896,
1993.
33.
Williams, R. J.,
N. Murphy,
J. Glowinski,
and
J. Prémont.
Glucose regulates glutamate-evoked arachidonic acid release from cultured striatal neurons.
J. Neurochem.
65:
241-249,
1995[Medline].
34.
Zhou, X. B.,
P. Ruth,
J. Schlossmann,
F. Hofmann,
and
M. Korth.
Protein phosphatase 2A is essential for the activation of Ca2+-activated K+ currents by cGMP-dependent protein kinase in tracheal smooth muscle and Chinese hamster ovary cells.
J. Biol. Chem.
271:
19760-19767,
1996
35.
Zou, A. P.,
J. T. Fleming,
J. R. Falck,
E. R. Jacobs,
D. Gebremedhin,
D. R. Harder,
and
R. J. Roman.
Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K+-channel activity.
Am. J. Physiol.
270 (Renal Fluid Electrolyte Physiol. 39):
F822-F832,
1996
This article has been cited by other articles:
![]() |
R. T. Worrell, H.-F. Bao, D. D. Denson, and D. C. Eaton Contrasting effects of cPLA2 on epithelial Na+ transport Am J Physiol Cell Physiol, July 1, 2001; 281(1): C147 - C156. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Herzig and J. Neumann Effects of Serine/Threonine Protein Phosphatases on Ion Channels in Excitable Membranes Physiol Rev, January 1, 2000; 80(1): 173 - 210. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |